Xeloda-Warfarin Black Box Warning To Be Subject Of Roche Letter To Doctors
Executive Summary
Roche is preparing a letter to physicians highlighting a black box warning about interactions between Xeloda (capecitabine) and warfarin following FDA's Sept. 7 approval of the labeling change.